Specialty Overview

Best Hospitals for Gastrointestinal Stromal Tumor Treatment in Mumbai, India

17 surgical gastroenterology hospitals in our India network are listed in Mumbai, accredited by JCI, NABH, NABL, ISO 9001, with 6,503 beds combined.

17
Hospitals Listed
1
City
4.6
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the surgical gastroenterology hospitals in our directory offering Gastrointestinal Stromal Tumor Treatment in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.

Ask us about gastrointestinal stromal tumor treatment in Mumbai, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 17 accredited hospitals for Surgical Gastroenterology in Mumbai, India

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviewsAccredited by JCI, NABH350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
Accredited by JCI, NABH

Patients considering gastrointestinal stromal tumor treatment can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering gastrointestinal stromal tumor treatment can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviewsAccredited by NABH629 beds
Specialties & Accreditation
OncologyCancer Center
Accredited by NABH

Patients considering gastrointestinal stromal tumor treatment can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Apollo Hospitals, Navi Mumbai

🇮🇳 Apollo Hospitals, Navi Mumbai

Mumbai, India 4.8 (512 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 512 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Accredited by JCI, NABH

Patients considering gastrointestinal stromal tumor treatment can be cared for by Apollo Hospitals, Navi Mumbai's care team in Mumbai, India, from initial consultation through recovery. Apollo Hospitals, Navi Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

4.8/5
Rating
2016
Established
500
Beds
Mumbai, India
Location
Gleneagles Hospital, Mumbai

🇮🇳 Gleneagles Hospital, Mumbai

Mumbai, India 4.8 (615 reviews) 638 beds
Why consider this hospital?
4.8/5 rating from 615 reviewsAccredited by JCI, NABH638 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering gastrointestinal stromal tumor treatment can be cared for by Gleneagles Hospital, Mumbai's care team in Mumbai, India, from initial consultation through recovery. Gleneagles Hospital, Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

4.8/5
Rating
2008
Established
638
Beds
Mumbai, India
Location
Lilavati Hospital And Research Centre

🇮🇳 Lilavati Hospital And Research Centre

Mumbai, India 4.8 (724 reviews) 326 beds
Why consider this hospital?
4.8/5 rating from 724 reviewsAccredited by JCI, NABH326 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
Accredited by JCI, NABH

Patients considering gastrointestinal stromal tumor treatment can be cared for by Lilavati Hospital And Research Centre's care team in Mumbai, India, from initial consultation through recovery. Lilavati Hospital And Research Centre, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

4.8/5
Rating
1997
Established
326
Beds
Mumbai, India
Location
Jaslok Hospital

🇮🇳 Jaslok Hospital

Mumbai, India 4.6 (129 reviews) 350 beds
Why consider this hospital?
4.6/5 rating from 129 reviewsAccredited by NABH, NABL350 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesOncologyOrthopedicsTransplant
Accredited by NABH, NABL

Patients considering gastrointestinal stromal tumor treatment can be cared for by Jaslok Hospital's care team in Mumbai, India, from initial consultation through recovery. Jaslok Hospital, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

4.6/5
Rating
1973
Established
350
Beds
Mumbai, India
Location
Gleneagles Global Hospitals (Global Hospitals)

🇮🇳 Gleneagles Global Hospitals (Global Hospitals)

Parel, Mumbai, India 4.6 (183 reviews) 450 beds
Why consider this hospital?
4.6/5 rating from 183 reviewsAccredited by NABH, JCI450 beds
Specialties & Accreditation
Liver TransplantCardiac SurgeryOrthopedicsOncologyNeurosciences
Accredited by NABH, JCI

Patients considering gastrointestinal stromal tumor treatment can be cared for by Gleneagles Global Hospitals (Global Hospitals)'s care team in Parel, Mumbai, India, from initial consultation through recovery. Gleneagles Global Hospitals (Global Hospitals), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

4.6/5
Rating
1996
Established
450
Beds
Parel, Mumbai, India
Location
Medicover Hospital, Navi Mumbai

🇮🇳 Medicover Hospital, Navi Mumbai

Navi Mumbai, India 4.6 (143 reviews) 310 beds
Why consider this hospital?
4.6/5 rating from 143 reviewsAccredited by NABH310 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyOrthopedicsNeurologyGastroenterology
Accredited by NABH

Patients considering gastrointestinal stromal tumor treatment can be cared for by Medicover Hospital, Navi Mumbai's care team in Navi Mumbai, India, from initial consultation through recovery. Medicover Hospital, Navi Mumbai, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

4.6/5
Rating
2023
Established
310
Beds
Navi Mumbai, India
Location
KIMS Hospitals, Thane

🇮🇳 KIMS Hospitals, Thane

Mumbai, India 4.6 (58 reviews) 300 beds
Why consider this hospital?
4.6/5 rating from 58 reviewsAccredited by NABH300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsSpine Surgery
Accredited by NABH

Patients considering gastrointestinal stromal tumor treatment can be cared for by KIMS Hospitals, Thane's care team in Mumbai, India, from initial consultation through recovery. KIMS Hospitals, Thane, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing gastrointestinal stromal tumor treatment.

4.6/5
Rating
2025
Established
300
Beds
Mumbai, India
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Surgical Gastroenterology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Gastrointestinal Stromal Tumor Treatment in Mumbai, India?

Choosing the right hospital for gastrointestinal stromal tumor treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include surgical gastroenterology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Gastrointestinal Stromal Tumor Treatment

Gastrointestinal Stromal Tumor (GIST) treatment encompasses a multidisciplinary approach combining targeted molecular therapy (primarily imatinib and sunitinib), precision oncological surgery, and advanced pathological staging, achieving long-term disease control in over 80% of localized GIST cases and meaningful remission in metastatic disease.

7–14 days (varies by surgical extent and medical management phase)
Hospital Stay
3–6 weeks (longer for open resections or complex cytoreductive procedures; targeted therapy patients may travel earlier with oncologist clearance)
Total Stay in Country (Fit-to-Fly)
85–90% for localized GIST (R0 resection); 70–80% progression-free survival at 1 year for metastatic disease on first-line imatinib
Success Rate

Clinical Overview

  • Gastrointestinal Stromal Tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract, arising predominantly from the interstitial cells of Cajal or their precursors.
  • They occur most frequently in the stomach (60%) and small intestine (25%), with the remainder distributed across the colon, rectum, esophagus, and mesentery.
  • Unlike epithelial GI cancers, GISTs are defined by activating mutations in the KIT proto-oncogene (approximately 75–80% of cases), PDGFRA (10–15%), or, in a minority of cases, by NF1 mutations, SDH deficiency, or BRAF alterations.
Full details →

Who is a Candidate?

  • CONFIRMED GIST DIAGNOSIS: Patients with histologically confirmed GIST via endoscopic ultrasound-guided fine-needle biopsy (EUS-FNA), CT/MRI-guided core needle biopsy, or surgical specimen with immunohistochemistry positive for CD117 (KIT), DOG1, and/or CD34
  • MOLECULAR PROFILING REQUIRED: KIT exon 9, 11, 13, 17 and PDGFRA exon 12, 14, 18 mutational analysis is mandatory before initiating TKI therapy; SDH subunit testing for wild-type GIST
  • SURGICAL CANDIDATES: Patients with localized, resectable GIST (ECOG performance status 0–2) without major comorbidities precluding general anesthesia; tumor size and location must be assessed for feasibility of R0 resection
  • NEOADJUVANT IMATINIB CANDIDATES: Patients with large (>5 cm), borderline resectable, or anatomically complex tumors (gastroesophageal junction, duodenum, rectum) where preoperative TKI downsizing improves surgical outcomes or enables organ-sparing resection
  • +5 more

Treatment Options & Approaches

  • SURGICAL APPROACHES:

Recovery

  • PHASE 1 — PRE-ARRIVAL (2–4 weeks before travel):

Risks to be aware of

  • GIST treatment carries procedure-specific and therapy-specific risks that must be transparently communicated to all international patients.
  • Surgical risks include intraoperative tumor rupture (which upstages disease and worsens prognosis — incidence approximately 5–10% in experienced centers), anastomotic leak (2–5% for bowel resections), hemorrhage requiring transfusion, wound infection, and ileus.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive end-to-end logistical support specifically designed for international oncology patients traveling to India or the UAE for GIST treatment.

Common questions about Gastrointestinal Stromal Tumor Treatment

What is the cost of GIST treatment in India compared to the UAE?
The cost of GIST treatment in India typically ranges from USD 4,500 to USD 12,000 for a complete treatment episode including surgery (laparoscopic or open resection), hospitalization, pathology with molecular profiling, and initial post-operative care. In the UAE (Dubai or Abu Dhabi), the equivalent treatment costs between USD 12,000 and USD 28,000, reflecting the higher operational costs of UAE healthcare facilities while still representing significant savings compared to Western countries where GIST surgery alone can exceed USD 60,000–120,000. Both destinations offer JCI-accredited hospitals with access to the full spectrum of targeted therapies including imatinib, sunitinib, regorafenib, ripretinib, and avapritinib. It is important to note that ongoing tyrosine kinase inhibitor (TKI) therapy — typically 3 years of adjuvant imatinib for high-risk resected GIST — represents an additional ongoing medication cost; generic imatinib is substantially less expensive in India than in the UAE or Western markets. GAF Healthcare provides a detailed, itemized cost estimate after review of the patient's specific case, tumor characteristics, and planned treatment modality.
How long do I need to stay in India or the UAE before I am fit to fly home after GIST treatment?
The duration of stay required before safe long-haul air travel depends directly on the treatment modality received. Patients who undergo laparoscopic or robotic-assisted GIST resection generally require a minimum of 3–4 weeks in-country: approximately 5–8 days of hospitalization, followed by 2–3 weeks of outpatient recovery for wound healing, return of bowel function, and post-operative pathology review. Clearance for long-haul flights (over 6 hours) is typically given at the 3–4 week mark, provided there are no complications. Patients who undergo open (laparotomy) resection — typically for larger or more complex GISTs — require 4–6 weeks before long-haul travel is considered safe, as the risk of ileus, wound dehiscence, and deep vein thrombosis (DVT) is higher in the immediate post-operative period. For all surgical patients, compression stockings and, in some cases, low-molecular-weight heparin prophylaxis are prescribed for the flight. Patients being treated with systemic targeted therapy alone (neoadjuvant imatinib for downsizing, or first-line TKI for metastatic GIST) can typically travel within 1–2 weeks of treatment initiation, once baseline tolerability of the drug is confirmed and any initial side effects (edema, nausea, fatigue) are managed. GAF Healthcare's medical team will issue a formal fit-to-fly clearance letter, which patients should carry alongside their discharge summary.
What is the success rate of GIST treatment, and what factors influence outcomes?
The success rate of GIST treatment is highly favorable compared to most other gastrointestinal malignancies, particularly when the tumor is diagnosed at a localized stage and treated with complete surgical resection (R0) followed by appropriate adjuvant targeted therapy. For localized, completely resected GIST in patients who receive 3 years of adjuvant imatinib (KIT-mutated, intermediate- to high-risk tumors), the 5-year recurrence-free survival rate is approximately 65–70%, with 5-year overall survival exceeding 85–90% in high-volume sarcoma centers. For very low- and low-risk resected GISTs (small tumor, low mitotic index), surgery alone achieves 5-year survival rates approaching 95%. For metastatic or unresectable GIST treated with first-line imatinib, objective response rates (complete plus partial response) are approximately 50–60%, with disease stabilization in an additional 25–30% of patients; median progression-free survival on imatinib is approximately 18–24 months. The introduction of subsequent-line TKIs has extended median overall survival in metastatic GIST to over 5 years in contemporary series. Key factors influencing outcomes include the primary mutation type (KIT exon 11-mutated tumors respond best to imatinib; KIT exon 9-mutated tumors require higher-dose imatinib; PDGFRA D842V-mutated tumors are imatinib-resistant but highly responsive to avapritinib), tumor size, mitotic rate, primary site, completeness of surgical resection (R0 vs. R1/R2), and avoidance of intraoperative tumor rupture. GAF Healthcare connects patients with high-volume sarcoma units that have treated over 500 GIST cases, which is associated with significantly better surgical and oncological outcomes compared to general surgery settings.

How GAF Healthcare Assists in Choosing the Best Hospital for Gastrointestinal Stromal Tumor Treatment in Mumbai, India

Discover the Top Hospitals for Gastrointestinal Stromal Tumor Treatment in Mumbai, India

This page lists 17 accredited surgical gastroenterology hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about gastrointestinal stromal tumor treatment in Mumbai, India

How many surgical gastroenterology hospitals are listed in Mumbai, India?
17 hospitals in our Mumbai, India directory are currently listed for surgical gastroenterology including Gastrointestinal Stromal Tumor Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Surgical Gastroenterology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there surgical gastroenterology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO 9001 — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for gastrointestinal stromal tumor treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about gastrointestinal stromal tumor treatment in Mumbai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for gastrointestinal stromal tumor treatment in Mumbai, India.

Contact us to report an inaccuracy on this page.